According to the World Health Organization, 360 million people worldwide suffer from hearing loss. In deaf subjects, direct electrical stimulation of SGNs by CIs enable open speech comprehension in the majority of them1,2,4,5. Even though CIs have been implanted in more than 200,000 people, therefore being the most successful neuroprosthesis, sound encoding driven by the current cochlear implants is limited. CIs are based on electrical stimulation by a certain number of electrodes where each one activates a tonotopic region of the auditory nerve thus bypassing the dysfunctional sensory organ of Corti in the cochlea. Normal hearing listeners can discriminate more than 2,000 frequencies, however today's CIs use only up to 12-22 frequency channels4. This is due to widespread current flow from each stimulating electrode7,9, activating a large number of SGNs that represent many different sound frequencies8,15. This limitation can be improved using multipolar stimulation but at the expense of higher power consumption16,17. Their output dynamic range for sound intensity is also limited, typically below 6-20 dB4,18. For these reasons, improving frequency and intensity resolution are important objectives for increasing CI performance to ameliorate speech recognition in noisy environments, prosody comprehension and music perception.
A different option to stimulate the auditory nerve is optical stimulation. Light can be conveniently focused to target a small SGN population, promising better spatial confinement, increasing frequency resolution and also widening dynamic range, resulting in a better intensity resolution. Indeed, cochlear stimulation with infrared light has shown excellent frequency resolution in animal models10,11,19. One disadvantage of this kind of stimulation is that it requires higher energies than electrical stimulation10,11. Moreover, concerns about the ability of the method to directly stimulate auditory neurons have been raised12,20.
As an alternative to infrared stimulation, we employ optogenetics to render SGNs light sensitive. Optogenetics is a novel approach that combines genetic and optical techniques to non-invasively and specifically control cells with high temporal precision (reviews21-23). The currently most frequently used modality employs the expression of the microbial channelrhodopsin 2 (ChR2) gene of Chlamydomonas reinhardtii and variants thereof, encoding a light-gated cation channel24. ChR2 is a 7-transmembrane-helix protein that, when transduced into neurons and activated by blue light, acts as non-selective cation channel, thus depolarizing the cells24-27. ChR2 has been well characterized24,28-31 and many variants have been developed to modify action spectrum, gating and permeability properties32,33. The aim of our work is to establish cochlear optogenetics for the activation of the auditory pathway. We note that the optogenetic approach to stimulate the auditory nerve requires genetic manipulation of the spiral ganglion for the expression of channelrhodopsin. Working with mice and rats allows the use of available transgenic animals13,34,35, which provide expression of channelrhodopsin with little variability along the tonotopic axis and across animals36. Combining conditional alleles37 with appropriate Cre-lines provides for cell-specific expression. Gene transfer into the spiral ganglion of other animals requires the use of virus such as adeno-associated virus that is a standard approach in optogenetics38 and that we showed to work well in mice36. Genetic manipulation and expression of transgenes encoding alien proteins bear risks for adverse effects such as immune responses and/or proliferation, compromised condition or even death of genetically manipulated cells. For the purpose of this demonstration we use transgenic mice expressing ChR2 in spiral ganglion neurons under the Thy-1 promotor13 to optically stimulate the auditory pathway. We note that other channelrhodopsin variants can be used for the same purpose as we demonstrated using virus-mediated transfer of the variant CatCh14 into SGNs39.
While cochlear optogenetics requires genetic manipulation, it offers molecular tuning for optimized SGN stimulation and promises improved frequency and intensity resolution when compared to electrical stimulation. Optogenetic stimulation of the auditory pathway is highly relevant for hearing research. For example, it promises advances in studies of the activity-dependent refinement of tonotopy during development, in the analysis of the requirement for spectral integration in sound localization and of the extent of interaction between frequency-specific afferent projections in the central auditory system.